Check the time stamp on this data. Updated AI-Generated Signals for Greenwich Lifesciences Inc. (GLSI) available here: GLSI.

Greenwich LifeSciences (NASDAQ:GLSI) just reported results for the first quarter of 2024. Greenwich LifeSciences reported earnings per share of -19 cents. This was above the analyst estimate for ...

STAFFORD, Texas, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial ...

Greenwich Lifesciences shares are trading higher by 30.6% Wednesday afternoon. The company provided an update on the Phase III clinical trial, Flamingo-01.

Find the latest Greenwich LifeSciences, Inc. GLSI analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Laudato Si’ Movement in Indonesia (GLSI) has launched a new drive to establish community-based environmental advocacy groups ...

* Price is based on Glass's Information Services third party pricing data for the lowest priced Proton Jumbuck 2008 variant. The Price excludes costs such as stamp duty, other government charges and ...

The overall quant rating is not an average of the factor grades listed. Instead, it gives greater weight to the metrics with the strongest predictive value.